Bruno Permanne

2.3k total citations · 1 hit paper
18 papers, 1.8k citations indexed

About

Bruno Permanne is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Bruno Permanne has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 11 papers in Molecular Biology and 4 papers in Organic Chemistry. Recurrent topics in Bruno Permanne's work include Alzheimer's disease research and treatments (13 papers), Glycosylation and Glycoproteins Research (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Bruno Permanne is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Glycosylation and Glycoproteins Research (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Bruno Permanne collaborates with scholars based in United States, Switzerland and Italy. Bruno Permanne's co-authors include Claudio Soto, Gabriela P. Saborı́o, Blas Frangione, Thomas Wısnıewskı, Einar M. Sigurdsson, Santiago Fraga, Céline Adessi, Jo Van Dorpe, William A. Banks and Miguel Calero and has published in prestigious journals such as Nature, Biochemical Journal and Brain Research.

In The Last Decade

Bruno Permanne

18 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding

2001 961 citations Gabriela P. Saborı́o, Bruno Permanne et al. Nature profile →

Peers

Bruno Permanne

PHYSI

NEURO

PHARM

Henrieta Scholtzova United States

Nadia Angeretti Italy

Fabio Moda Italy

Lars Stoltze Germany

Jeppe Falsig Switzerland

Emiliano Biasini Italy

Lillian M. Shaffer United States

Brian O’Nuallain United States

Tommy Saing United States

Menglan Yuan United States

Henrieta Scholtzova United States

Bruno Permanne

889 ×0.7

1.3k ×1.6

PHYSI

689 ×1.3

NEURO

262 ×0.8

286 ×1.6

PHARM

Citations per year, relative to Bruno Permanne Bruno Permanne (= 1×) peers Henrieta Scholtzova

Countries citing papers authored by Bruno Permanne

Since Specialization

Citations

This map shows the geographic impact of Bruno Permanne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Permanne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Permanne more than expected).

Fields of papers citing papers by Bruno Permanne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Permanne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Permanne. The network helps show where Bruno Permanne may publish in the future.

Co-authorship network of co-authors of Bruno Permanne

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno Permanne. A scholar is included among the top collaborators of Bruno Permanne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno Permanne. Bruno Permanne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Permanne, Bruno, et al.. (2022). O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies. ACS Chemical Neuroscience. 13(8). 1296–1314. 52 indexed citations

Ryan, J. Michael, Anna Quattropani, Izaak den Daas, et al.. (2018). O1‐12‐05: PHASE 1 STUDY IN HEALTHY VOLUNTEERS OF THE O‐GLCNACASE INHIBITOR ASN120290 AS A NOVEL THERAPY FOR PROGRESSIVE SUPRANUCLEAR PALSY AND RELATED TAUOPATHIES. Alzheimer s & Dementia. 14(7S_Part_4). 25 indexed citations

Permanne, Bruno, et al.. (2015). O3‐04‐04: Pharmacological intervention with the novel o‐glcnacase inhibitor ASN‐561 reduces pathological tau in transgenic mice. Alzheimer s & Dementia. 11(7S_Part_5). 13 indexed citations

Quattropani, Anna, et al.. (2014). O1‐10‐01: PRECLINICAL PROFILES OF DRUG CANDIDATES PROMOTING O‐LINKED GLYCOSYLATION OF TAU FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND TAUOPATHIES. Alzheimer s & Dementia. 10(4S_Part_1). 1 indexed citations

Hering, Heike, Danielle Graham, Audrey Gray, et al.. (2013). Novel non-carbohydrate O-GlcNAcase inhibitors with CNS drug properties as potential treatment for Alzheimer’s disease and tauopathies. Molecular Neurodegeneration. 8(S1). 7 indexed citations

Permanne, Bruno, et al.. (2012). Development and Characterization of a Novel Membrane Assay for Full-Length BACE-1 at pH 6.0. SLAS DISCOVERY. 18(3). 277–285. 4 indexed citations

Baguet, Aurélie, Christophe Losberger, Stéphane Genoud, et al.. (2012). Substrate determinants in the C99 juxtamembrane domains differentially affect γ–secretase cleavage specificity and modulator pharmacology. Journal of Neurochemistry. 125(4). 610–619. 20 indexed citations

Permanne, Bruno, et al.. (2002). Are β-sheet breaker peptides dissolving the therapeutic problem of Alzheimer’s disease?. Journal of neural transmission. Supplementum. 293–301. 28 indexed citations

Permanne, Bruno, Céline Adessi, Gabriela P. Saborı́o, et al.. (2002). Reduction of amyloid load and cerebral damage in transgenic mouse model of Alzheimer's disease by treatment with a β‐sheet breaker peptide. The FASEB Journal. 16(8). 860–862. 183 indexed citations

10.

Saborı́o, Gabriela P., Bruno Permanne, & Claudio Soto. (2001). Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 411(6839). 810–813. 961 indexed citations breakdown →

11.

Ji, Yong, Bruno Permanne, Einar M. Sigurdsson, David M. Holtzman, & Thomas Wısnıewskı. (2001). Amyloid β40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice. Journal of Alzheimer s Disease. 3(1). 23–30. 75 indexed citations

12.

Soto, Claudio, Gabriela P. Saborı́o, & Bruno Permanne. (2000). Inhibiting the conversion of soluble amyloid-β peptide into abnormally folded amyloidogenic intermediates: relevance for Alzheimer's disease therapy. Acta Neurologica Scandinavica. 102. 90–95. 30 indexed citations

13.

Sigurdsson, Einar M., Bruno Permanne, Claudio Soto, Thomas Wısnıewskı, & Blas Frangione. (2000). In Vivo Reversal of Amyloid-β Lesions in Rat Brain. Journal of Neuropathology & Experimental Neurology. 59(1). 11–17. 67 indexed citations

14.

Tokuda, Takahiko, Miguel Calero, Etsuro Matsubara, et al.. (2000). Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β peptides. Biochemical Journal. 348(2). 359–365. 220 indexed citations

15.

Permanne, Bruno, Gabriela P. Saborı́o, & Claudio Soto. (2000). In vivo disrupting of amyloid deposition after injection of β-sheet breaker peptide into cerebral ventricle. Neurobiology of Aging. 21. 87–87. 1 indexed citations

16.

Wısnıewskı, Thomas, W. K. Dowjat, Bruno Permanne, et al.. (1997). Presenilin-1 is associated with Alzheimer's disease amyloid.. PubMed. 151(2). 601–10. 21 indexed citations

17.

Permanne, Bruno, et al.. (1997). Detection of Apolipoprotein E/Dimeric Soluble Amyloid β Complexes in Alzheimer's Disease Brain Supernatants. Biochemical and Biophysical Research Communications. 240(3). 715–720. 54 indexed citations

18.

Permanne, Bruno, Luc Buée, Jean‐Philippe David, et al.. (1995). Quantitation of Alzheimer's amyloid peptide and identification of related amyloid proteins by dot-blot immunoassay. Brain Research. 685(1-2). 154–162. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact